X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE SANOFI INDIA TTK HEALTHCARE/
SANOFI INDIA
 
P/E (TTM) x 32.9 32.9 100.0% View Chart
P/BV x 6.1 6.3 96.7% View Chart
Dividend Yield % 0.5 1.4 33.3%  

Financials

 TTK HEALTHCARE   SANOFI INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
SANOFI INDIA
Dec-16
TTK HEALTHCARE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs6634,560 14.5%   
Low Rs3994,400 9.1%   
Sales per share (Unadj.) Rs535.61,028.5 52.1%  
Earnings per share (Unadj.) Rs15.9129.0 12.4%  
Cash flow per share (Unadj.) Rs20.0186.0 10.8%  
Dividends per share (Unadj.) Rs4.0068.00 5.9%  
Dividend yield (eoy) %0.81.5 49.6%  
Book value per share (Unadj.) Rs137.6753.6 18.3%  
Shares outstanding (eoy) m7.7723.03 33.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.4 22.8%   
Avg P/E ratio x33.334.7 95.9%  
P/CF ratio (eoy) x26.524.1 110.1%  
Price / Book Value ratio x3.95.9 64.9%  
Dividend payout %25.152.7 47.6%   
Avg Mkt Cap Rs m4,127103,174 4.0%   
No. of employees `0001.73.6 47.1%   
Total wages/salary Rs m6073,592 16.9%   
Avg. sales/employee Rs Th2,436.76,537.7 37.3%   
Avg. wages/employee Rs Th355.2991.4 35.8%   
Avg. net profit/employee Rs Th72.5819.8 8.8%   
INCOME DATA
Net Sales Rs m4,16223,686 17.6%  
Other income Rs m61708 8.6%   
Total revenues Rs m4,22324,394 17.3%   
Gross profit Rs m1975,281 3.7%  
Depreciation Rs m321,313 2.4%   
Interest Rs m3015 199.3%   
Profit before tax Rs m1974,661 4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,691 4.3%   
Profit after tax Rs m1242,970 4.2%  
Gross profit margin %4.722.3 21.2%  
Effective tax rate %37.036.3 102.0%   
Net profit margin %3.012.5 23.7%  
BALANCE SHEET DATA
Current assets Rs m1,62915,673 10.4%   
Current liabilities Rs m1,0586,678 15.8%   
Net working cap to sales %13.738.0 36.1%  
Current ratio x1.52.3 65.6%  
Inventory Days Days3076 39.2%  
Debtors Days Days3422 150.5%  
Net fixed assets Rs m5568,098 6.9%   
Share capital Rs m78230 33.7%   
"Free" reserves Rs m87817,088 5.1%   
Net worth Rs m1,06917,356 6.2%   
Long term debt Rs m1590-   
Total assets Rs m2,39925,400 9.4%  
Interest coverage x7.6311.7 2.4%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.70.9 186.0%   
Return on assets %6.411.8 54.5%  
Return on equity %11.617.1 67.7%  
Return on capital %18.526.9 68.5%  
Exports to sales %0.824.5 3.2%   
Imports to sales %1.428.0 5.0%   
Exports (fob) Rs m335,801 0.6%   
Imports (cif) Rs m586,627 0.9%   
Fx inflow Rs m337,145 0.5%   
Fx outflow Rs m636,846 0.9%   
Net fx Rs m-30299 -10.1%   
CASH FLOW
From Operations Rs m1273,226 3.9%  
From Investments Rs m-146-1,555 9.4%  
From Financial Activity Rs m22-1,818 -1.2%  
Net Cashflow Rs m3-147 -1.7%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 3.7 14.4 25.7%  
FIIs % 5.2 14.6 35.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.5 245.7%  
Shareholders   12,723 15,184 83.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS